1α,24-Dihydroxyvitamin D3 (tacalcitol) is effective against Hailey- Hailey disease both in vivo and in vitro

British Journal of Dermatology

Volumn 139, Issue 5, 1998, Pages 897-901

  Aoki, T ^a   Hashimoto, H ^a   Koseki, S ^a   Hozumi, Y ^a   Kondo, S ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; TACALCITOL; 1 ALPHA,24 DIHYDROXYVITAMIN D3; 1 ALPHA,24-DIHYDROXYVITAMIN D3; ANTIINFLAMMATORY AGENT; DIHYDROXYCOLECALCIFEROL;

ACANTHOLYSIS; ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DRUG EFFICACY; EXPLANT; GENODERMATOSIS; HAILEY HAILEY DISEASE; HUMAN; HUMAN TISSUE; KERATINOCYTE; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN CULTURE; TOPICAL DRUG ADMINISTRATION; AGED; CULTURE TECHNIQUE; DRUG EFFECT; INGUINAL REGION;

AGED; ANTI-INFLAMMATORY AGENTS; CULTURE TECHNIQUES; DIHYDROXYCHOLECALCIFEROLS; GROIN; HUMANS; KERATINOCYTES; MALE; PEMPHIGUS, BENIGN FAMILIAL;

EID: 0031593825     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02522.x     Document Type: Article

References (33)

1. Hailey H, Hailey H. Familial benign chronic pemphigus. Arch Dermatol Syphilol 1939; 39: 679-85.
2. Palmer DD, Perry HO. Benign familial chronic pemphigus. Arch Dermatol 1962; 86: 493-502.
3. Pye RJ. Benign familial chronic pemphigus. In: Textbook of Dermatology (Champion RH, Burton JL, Ebling FJG, eds), Vol. 2, 5th edn. Oxford: Blackwell Scientific Publications, 1992; 1636-8.
4. Sire DJ, Johnson BL. Benign familial chronic pemphigus treated with dapsone. Arch Dermatol 1971; 103: 262-5.
5. Thorne FL, Hall JH, Mladick RA. Surgical treatment of familial chronic pemphigus (Hailey-Hailey disease). Arch Dermatol 1968; 98: 522-4.
6. Shelley WB, Randall P. Surgical eradication of familial benign chronic pemphigus from the axillae. Arch Dermatol 1969; 100: 275-6.
7. Crotty CP, Scheen SR III, Masson JK et al. Surgical treatment of familial benign chronic pemphigus. Arch Dermatol 1981; 117: 540-2.
8. Berger RS, Lynch PJ. Familial benign chronic pemphigus: surgical treatment and pathogenesis. Arch Dermatol 1971; 104: 380-4.
9. 3 on the growth of human keratinocytes. J Dermatol 1990; 17: 97-103.
10. 3, a novel active form of vitamin D3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity. J Dermatol 1990; 17: 135-42.
11. 3 analogue, 1α,24-dihydroxycholecalciferol. Br J Dermatol 1986; 115: 431-3.
12. 3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol 1994; 131: 57-63.
13. Scarpa C. Tacalcitol ointment is an efficacious and well tolerated treatment for psoriasis. J Eur Acad Dermatol Venereol 1996; 6: 142-6.
14. Van de Kerhof PCM, Werfel T, Haustein UF et al. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre. placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol 1996; 135: 758-65.
15. Veien NK, Bjerke JR, Rossmann-Ringdahl I et al. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. a double-blind trial. Br J Dermatol 1997; 137: 581-6.
16. Ishibashi Y, Kajiwara Y, Ando I et al. The nature and pathogenesis of dyskeratosis in Hailey-Hailey's disease and Darier's disease. J Dermatol 1984; 11: 335-53.
17. Johnson B Jr, Honig P. Familial benign pemphigus. In: Histopathology of the Skin, 7th edn (Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, eds). Philadelphia: Lippincott-Raven Publishers, 1997; 131-2.
18. Kragballe K, Steijlen PM, Ibsen HH et al. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Arch Dermatol 1995; 131: 556-60.
19. 3 (tacalcitol) for steroid-resistant prurigo. Br J Dermatol 1996; 135: 237-40.
20. Biagini G, Costa AM, Laschi R. An electron microscopic sturdy of Darier's disease. J Cutan Pathol 1975; 2: 47-9.
21. Mann PR, Haye KR. An electron microscopic sturdy on the acantholytic and dyskeratotic processes in Darier's disease. Br J Dermatol 1970; 82: 561-6.
22. De Dobbeleer G, Achten G. Disrupted desmosomes in induced lesions of familial benign chronic pemphigus. J Cutan Pathol 1979; 6: 418-24.
23. Pierard J, Kint A. Die Dariersche Krankheit: eine electronemikroskopische Studie. Arch Klin Exp Dermatol 1968; 231: 382-97.
24. Ackerman AB. Focal acantholytic dyskeratosis. Arch Dermatol 1972; 106: 702-6.
25. Wilgram GF, Caulfield JB, Lever WF. An electron microscopic sturdy of acantholysis and dyskeratosis in Hailey and Hailey's disease. J Invest Dermatol 1962; 39: 373-81.
26. Abell E. Immunopathological investigation of glycocalyx material in Darier's and Hailey-Hailey disease (abstract). J Invest Dermatol 1983; 80: 355.
27. Burge SM, Millard PR, Wonjnarowska F. Hailey-Hailey disease: a widespread abnormality of cell adhesion. Br J Dermatol 1991; 124: 329-32.
28. Burge SM. Adhesion molecules and related proteins in Darier's disease and Hailey-Hailey disease. Br J Dermatol 1992; 127: 335-43.
29. 3. J Biol Chem 1993; 268: 27371-80.
30. Carlesimo OA, Bottoni U, Bianchi L et al. Attivita terapeutica del calcitriolo nel merbo di Hailey-Hailey. Derm Clin 1985; 4: 255-63.
31. Bosco G, Leoni A. Malattia di Hailey-Hailey: evidenza di calcificazioni ectopiche in tre casi. Giorn Ital Derm Vener 1988; 123: 95-7.
32. Kragballe K. Treatment of psoriasis with calcipotriol and other vitamin D analogues. J Am Acad Dermatol 1992; 27: 1001-8.
33. Baadsgaard O, Traulsen J, Roed-Petersen J et al. Optimal concentration of tacalcitol in once-daily treatment of psoriasis. J Dermatol Treat 1995; 6: 145-50.